78 FR 81 pg. 24751 - Disease, Disability, and Injury Prevention and ControlSpecial Emphasis Panel (SEP): Initial Review
Type: NOTICEVolume: 78Number: 81Page: 24751
FR document: [FR Doc. 2013-09874 Filed 4-25-13; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and ControlSpecial Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Continuing Prospective Birth Cohort Study Involving Environmental Uranium Exposure in the Navajo Nation, Funding Opportunity Announcement (FOA) TS13-001, Initial Review.
In accordance with Section 10(a)(2) of the Federal AdvisoryCommittee Act (Pub. L. 92-463), the Centers for DiseaseControl and Prevention (CDC) announces the aforementioned SEP:
Time and Date: 12:00 p.m.-3:30 p.m., June 13, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to "Continuing Prospective Birth Cohort Study Involving Environmental Uranium Exposure in the Navajo Nation, FOA TS13-001."
Contact Person for More Information: Jane Suen, Dr.P.H, M.S., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488-4281.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office,Centers for Disease Control and Prevention.
[FR Doc. 2013-09874 Filed 4-25-13; 8:45 am]
BILLING CODE 4163-18-P